A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Clinical trial NCT07196774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07196774
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-23
- Primary completion
- 2027-12-01
- Enrollment
- 740
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.